J
Joshua A. Beckman
Researcher at Vanderbilt University Medical Center
Publications - 304
Citations - 36753
Joshua A. Beckman is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 64, co-authored 272 publications receiving 31072 citations. Previous affiliations of Joshua A. Beckman include Brigham and Women's Hospital & Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
TL;DR: Since most patients with diabetes die from complications of atherosclerosis, they should receive intensive preventive interventions proven to reduce their cardiovascular risk.
Journal ArticleDOI
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American college of cardiology/American heart association task force on practice guidelines
Lee A. Fleisher,Kirsten E. Fleischmann,Andrew D. Auerbach,Susan Barnason,Joshua A. Beckman,Biykem Bozkurt,Victor G. Davila-Roman,Marie Gerhard-Herman,Thomas A. Holly,Garvan C. Kane,Joseph E. Marine,M. Timothy Nelson,Crystal C. Spencer,Annemarie Thompson,Henry H. Ting,Barry F. Uretsky,Duminda N. Wijeysundera +16 more
TL;DR: The 2017-18 FACC/FAHA curriculum vitae will focus on adolescent and young adult FACC and FAHA education, as well as leadership, self-confidence, and self-consistency.
Journal ArticleDOI
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli,Mahesh V. Madhavan,David Jiménez,Taylor Chuich,Isaac Dreyfus,Elissa Driggin,Caroline Der Nigoghossian,Walter Ageno,Mohammad Madjid,Yutao Guo,Liang V. Tang,Yu Hu,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Joseph A. Caprini,Alfonso Tafur,John R. Burton,Dominic P. Francese,Elizabeth Y. Wang,Anna Falanga,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,John W. Eikelboom,Ido Weinberg,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,P. Gabriel Steg,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI
Advanced glycation end products: sparking the development of diabetic vascular injury.
TL;DR: Because of the emerging evidence about the adverse effects of AGEs on the vasculature of patients with diabetes, a number of different therapies to inhibit A GEs are under investigation.
Journal ArticleDOI
Diabetes and Vascular Disease Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
TL;DR: The present review will focus on the relationship of diabetes mellitus and atherosclerotic vascular disease, highlighting pathophysiology and molecular mechanisms (Part I) and clinical manifestations and management strategies (Part II).